| 注册
首页|期刊导航|武警医学|3种血清肿瘤标记物在判断非小细胞肺癌患者预后中的价值

3种血清肿瘤标记物在判断非小细胞肺癌患者预后中的价值

李雪冰 田慧芳 张同梅 鲁葆华 仝丽 张新勇 李宝兰

武警医学2011,Vol.22Issue(6):472-474,478,4.
武警医学2011,Vol.22Issue(6):472-474,478,4.

3种血清肿瘤标记物在判断非小细胞肺癌患者预后中的价值

Prognostic significance of serum MMP-9,endostatin and VEGF for patients with nonsmall cell lung cancer

李雪冰 1田慧芳 1张同梅 1鲁葆华 1仝丽 2张新勇 2李宝兰1

作者信息

  • 1. 101149,北京胸科医院综合科
  • 2. 101149,北京胸科医院肿瘤内科
  • 折叠

摘要

Abstract

Objective To investigate the prognostic value of serum MMP - 9, endostatin and VEGF levels in patients with non -small cell lung cancer.Methods Kaplan - Meier and Cox regression were used to analyze the relationship between survival time and prognostic factors in 112 patients with non - small cell lung cancer.The prognostic factors included clinical and laboratory parameters, serum matrix metalloproteinase - 9(MMP -9) ,endostatin(ES) ,and vascular endothelial growth factor( VEGF).Results Kaplan - Meier analysis showed poor prognosis both in male patients with PS ≥3, who were left untreated or in stage Ⅲ and Ⅳ,and in patients with serum MMP - 9 ≥ 685.23 ng/ L , ES ≥78.01 ng/ L Multivariate analysis indicated that serum MMP - 9 , staging of the disease and systematic treatment were independent prognostic factors.Conclusion The level of serum MMP - 9 is an independent prognostic factor.

关键词

非小细胞肺癌/基质金属蛋白酶9/血管内皮生长因子/内皮抑素/预后

Key words

non - small cell lung cancer, MMP - 9/ VEGF/ endostatin/ prognosis

分类

医药卫生

引用本文复制引用

李雪冰,田慧芳,张同梅,鲁葆华,仝丽,张新勇,李宝兰..3种血清肿瘤标记物在判断非小细胞肺癌患者预后中的价值[J].武警医学,2011,22(6):472-474,478,4.

武警医学

OACSTPCD

1004-3594

访问量0
|
下载量0
段落导航相关论文